Search Results - "Stelljes M"

The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.

Authors: Stelljes, M. van Biezen, A. Slavin, S. et al.

Source: Bone Marrow Transplantation. Dec2008, Vol. 42 Issue 11, p739-742. 4p. 2 Charts, 1 Graph.

Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.

Authors: Stelljes, M. Corbacioglu, A. Schlenk, R. F. et al.

Source: Leukemia (08876924). Jul2011, Vol. 25 Issue 7, p1209-1210. 2p. 2 Diagrams.

This result is not displayed to guests.
Login for full access.

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.

Authors: Schetelig, J Schaich, M Schäfer-Eckart, K et al.

Source: Leukemia (08876924). May2015, Vol. 29 Issue 5, p1060-1068. 9p. 2 Diagrams, 3 Charts, 3 Graphs.

Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.

Authors: Sauer, T Silling, G Groth, C et al.

Source: Bone Marrow Transplantation. Apr2015, Vol. 50 Issue 4, p485-492. 8p.

Molecular monitoring in NUP214-ABL-positive T-acute lymphoblastic leukemia reveals clonal diversity and helps to guide targeted therapy.

Authors: Koschmieder, S Burmeister, T Brüggemann, M et al.

Source: Leukemia (08876924). Feb2014, Vol. 28 Issue 2, p419-422. 4p. 1 Color Photograph, 1 Graph.

CD34⁺ lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCT.

Authors: Rosenow, F Berkemeier, A Krug, U et al.

Source: Bone Marrow Transplantation. Aug2013, Vol. 48 Issue 8, p1070-1076. 7p. 3 Charts, 3 Graphs.

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia.

Authors: Pfeifer, H Wassmann, B Bethge, W et al.

Source: Leukemia (08876924). Jun2013, Vol. 27 Issue 6, p1254-1262. 9p. 6 Charts, 3 Graphs.

Dose-escalated radioimmunotherapy as part of reduced intensity conditioning for allogeneic transplantation in patients with advanced high-grade non-Hodgkin lymphoma.

Authors: Bethge, W A von Harsdorf, S Bornhauser, M et al.

Source: Bone Marrow Transplantation. Nov2012, Vol. 47 Issue 11, p1397-1402. 6p. 1 Diagram, 2 Charts, 2 Graphs.

Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia.

Authors: Pfeifer, H Lange, T Wystub, S et al.

Source: Leukemia (08876924). Jul2012, Vol. 26 Issue 7, p1475-1481. 7p. 1 Chart, 6 Graphs.

1047P Contemporary outcomes of salvage high-dose chemotherapy (HDCT) in advanced germ cell tumors (GCTs): An analysis of the European Society for blood and marrow transplantation (EBMT) registry.

Authors: Tateo, V. Longoni, M. Secondino, S. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS706-S706. 1p.

Immunotherapy of B-cell malignancies with genetically engineered human CD8⁺ natural killer T cells.

Authors: Pieper, M. Scheffold, C. Duwe, S. et al.

Source: Leukemia (08876924). Apr2006, Vol. 20 Issue 4, p729-732. 4p. 1 Chart.

Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+donor cell chimerism analysis.

Authors: Scheffold, C. Kroeger, M. Zuehlsdorf, M. et al.

Source: Leukemia (08876924). Dec2004, Vol. 18 Issue 12, p2048-2050. 3p.

Bone Marrow Transplantation after Implantation of a Left Ventricular Assist Device.

Authors: Welp, H. Sindermann, J. Martens, S. et al.

Source: Thoracic & Cardiovascular Surgeon, Supplement. 2017 Supplement2, Vol. 65, pS1-S110. 110p.

Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation From Matched Unrelated Donors: Lessons From Extended Follow Up of a Randomized Trial on GVHD Prophylaxis With or Without Anti T-Cell Globulin ATG-Fresenius (ATG-F)

Authors: Finke, J. Schmoor, C. Bethge, W.A. et al.

Source: Biology of Blood & Marrow Transplantation. Feb2011 Supplement, Vol. 17 Issue 2, pS163-S163. 1p.

Intestinal graft-versus-host-disease staging by video capsule endoscopy.

Authors: Meister, T. Heinzow, H. Bisping, G. et al.

Source: Endoscopy. Supplement 2008, Vol. 40, pE144-E144. 1p.

What is the best path towards allogeneic transplantation in MDS and AML? A survey among German-spreaking centers for allogeneic hematopoietic stem cell transplantation.

Authors: Krause SW Bethge W Bug G et al.

Source: Annals of hematology [Ann Hematol] 2026 Jun 06; Vol. 105 (7). Date of Electronic Publication: 2026 Jun 06.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.

Authors: Berning P Maulhardt M Boyadzhiev H et al.

Source: Blood cancer journal [Blood Cancer J] 2026 Jun 02; Vol. 16 (1). Date of Electronic Publication: 2026 Jun 02.

Publication Type: Letter

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process

Beta-blocker use and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.

Authors: Werk J Baden D Shaforostova I et al.

Source: Annals of hematology [Ann Hematol] 2026 Mar 25; Vol. 105 (4). Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Authors: Kanellopoulos A Labopin M Spyridonidis A et al.

Source: Bone marrow transplantation [Bone Marrow Transplant] 2026 Jun 21. Date of Electronic Publication: 2026 Jun 21.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE